This product has not been evaluated by the FDA and is supplied solely for in-vitro laboratory research by qualified professionals
The FDA-reviewed prescribing information for Wegovy (semaglutide 2.4 mg) discloses that in the SELECT cardiovascular outcomes trial - which enrolled adults with established cardiovascular disease - hip and pelvis fractures were reported more often in female patients on Wegovy than in those on placebo: 1% (24 of 2,448 patients) versus 0.2% (5 of 2,424 patients)
Some people with ADHD describe improved focus and impulse control on semaglutide, which could reflect dopamine modulation, reduced inflammation, better sleep from weight loss, or simply the cognitive benefits of feeling more physically well
The Delphi panel took place between 29 August and 20 October 2025
Although easier said than done, try to maintain a consistent bedtime, practice mindfulness, and develop strategies to manage stress